Abstract
Patient compliance and safety is now prominent on the agenda of healthcare companies. Dysphagia (swallowing dysfunction) is common in general populations and more common in elderly institutionalized patients and persons in long-term care facilities due to significant primary illnesses, including cerebrovascular accidents, neurodegenerative disorders, head and neck cancer, or head injury. To ensure safety during oral medication administration, patients with dysphagia require an appropriate oral dosage form or modification of the dosage form. However inappropriate drug administration in patients with dysphagia (i.e., the crushing of sustained-release or enteric-coated tablets or the administration of oral medications with water) is undesirable and may be associated with adverse events (e.g. choking episodes, adverse drug reactions resulting from the immediate release of drug from a sustained-release product, refusal to take medications). Hence, there is a need of alternative novel oral dosage form like gels and jellies to deliver drugs having a viscosity that can be easily swallowed without any discomfort to the patient preventing choking and suffocation. Hence, today the potential for such dosage form is promising because of patient compliance and improved quality of life. This review briefly describes the role of gels and jellies in dysphagia patients, its advantages and disadvantages, formulation considerations, evaluation parameters and reviews of gels and jellies for dysphagia patients which have been carried out.
Keywords: Dysphagia, elderly patients, gels, jellies, patient compliance, semi-solid, dosage form, formulation of drugs, drug delivery, novel oral dosage
Current Drug Therapy
Title: Gels and Jellies as a Dosage Form for Dysphagia Patients: A Review
Volume: 6 Issue: 2
Author(s): Dixit A. Satyanarayana, Parthasarathi K. Kulkarni and Hosakote G. Shivakumar
Affiliation:
Keywords: Dysphagia, elderly patients, gels, jellies, patient compliance, semi-solid, dosage form, formulation of drugs, drug delivery, novel oral dosage
Abstract: Patient compliance and safety is now prominent on the agenda of healthcare companies. Dysphagia (swallowing dysfunction) is common in general populations and more common in elderly institutionalized patients and persons in long-term care facilities due to significant primary illnesses, including cerebrovascular accidents, neurodegenerative disorders, head and neck cancer, or head injury. To ensure safety during oral medication administration, patients with dysphagia require an appropriate oral dosage form or modification of the dosage form. However inappropriate drug administration in patients with dysphagia (i.e., the crushing of sustained-release or enteric-coated tablets or the administration of oral medications with water) is undesirable and may be associated with adverse events (e.g. choking episodes, adverse drug reactions resulting from the immediate release of drug from a sustained-release product, refusal to take medications). Hence, there is a need of alternative novel oral dosage form like gels and jellies to deliver drugs having a viscosity that can be easily swallowed without any discomfort to the patient preventing choking and suffocation. Hence, today the potential for such dosage form is promising because of patient compliance and improved quality of life. This review briefly describes the role of gels and jellies in dysphagia patients, its advantages and disadvantages, formulation considerations, evaluation parameters and reviews of gels and jellies for dysphagia patients which have been carried out.
Export Options
About this article
Cite this article as:
A. Satyanarayana Dixit, K. Kulkarni Parthasarathi and G. Shivakumar Hosakote, Gels and Jellies as a Dosage Form for Dysphagia Patients: A Review, Current Drug Therapy 2011; 6 (2) . https://dx.doi.org/10.2174/157488511795304921
DOI https://dx.doi.org/10.2174/157488511795304921 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mass Spectrometry Based Proteomics for Interrogating the Histone Code
Current Proteomics Drug-Eluting Stents: Present and Future
Cardiovascular & Hematological Agents in Medicinal Chemistry Theoretical Studies on Binding and Specificity Mechanisms of Farnesyltransferase (FTase) and Geranylgeranyltransferase Type-I (GGTase-I) Inhibitors by Molecular Modeling
Combinatorial Chemistry & High Throughput Screening Herpes Simplex Virus-Induced Ocular Diseases: Detrimental Interaction Between Virus and Host
Current Immunology Reviews (Discontinued) A Systems Biology Road Map for the Discovery of Drugs Targeting Cancer Cell Metabolism
Current Pharmaceutical Design Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications
Current Drug Targets Engineered Peptides for Applications in Cancer-Targeted Drug Delivery and Tumor Detection
Mini-Reviews in Medicinal Chemistry The History of the HSV Amplicon: From Naturally Occurring Defective Genomes to Engineered Amplicon Vectors
Current Gene Therapy Identifying Molecular Biomarker for the Lung Squamous Cell Carcinoma by Integrating Multifactorial Data
Current Bioinformatics Multidisciplinary Management of Aneurysmal Bone Cyst in Paediatric Patients: A Case Report
Current Medical Imaging Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases
Current Pharmaceutical Biotechnology Synthesis and Hypoxia Selective Radiosensitization Potential of β-2-FAZA and β-3-FAZL: Fluorinated Azomycin β-Nucleosides
Medicinal Chemistry DYRK1A Kinase Inhibitors with Emphasis on Cancer
Mini-Reviews in Medicinal Chemistry Micro- and Nano-particulate Strategies for Antigen Specific Immune Tolerance to Treat Autoimmune Diseases
Pharmaceutical Nanotechnology Mass Spectrometry Techniques: Principles and Practices for Quantitative Proteomics
Current Protein & Peptide Science Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology Curcumin: the Yellow Molecule with Pleiotropic Biological Effects
Letters in Drug Design & Discovery Nanostructural Hybrid Sensitizers for Photodynamic Therapy
Current Pharmaceutical Design New Light on An Old Friend: Targeting PUMA in Radioprotection and Therapy of Cardiovascular and Neurodegenerative Diseases
Current Drug Targets Clinical Trials in Chemoprevention of Head and Neck Cancers
Reviews on Recent Clinical Trials